Literature DB >> 23719858

In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.

Julien Dimastromatteo1, Alexis Broisat, Pascale Perret, Mitra Ahmadi, Didier Boturyn, Pascal Dumy, Daniel Fagret, Laurent M Riou, Catherine Ghezzi.   

Abstract

UNLABELLED: Vascular cell adhesion molecule 1 (VCAM-1) plays a major role in the chronic inflammatory processes involved in vulnerable atherosclerotic plaque development. We previously showed that the (99m)Tc-labeled major histocompatibility complex 1-derived peptide B2702p bound specifically to VCAM-1 and allowed the ex vivo imaging of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits. However, B2702p target-to-background ratio was suboptimal for the in vivo imaging of VCAM-1 expression in atherosclerotic lesions. To improve the target-to-background ratio, 20 derivatives of B2702p (B2702p1-B2702p20) were synthesized using the alanine scan methodology. We hypothesized that (99m)Tc-radiolabeled B2702p derivatives might allow the molecular imaging of VCAM-1 expression in an experimental model of atherosclerosis.
METHODS: A mouse model of focal atherosclerotic plaque development induced by left carotid artery ligation in apolipoprotein E double-knockout (ApoE(-/-)) mice was used (n = 82). (99m)Tc-B2702p and (99m)Tc-B2702p1-(99m)Tc-B2702p20 were injected intravenously in anesthetized animals 3 wk after the ligation. Whole-body planar imaging was performed for 3 h. SPECT imaging of 6 additional ligated ApoE(-/-) mice was also performed with (99m)Tc-B2702p1. The animals were then euthanized, and the biodistribution of (99m)Tc-labeled peptides was evaluated by γ-well counting of excised organs. Expression of VCAM-1 in the ligated and contralateral carotid arteries was evaluated by immunohistology.
RESULTS: Robust VCAM-1 immunostaining was observed in the left carotid atherosclerotic lesions as a consequence of artery ligation, whereas no VCAM-1 expression was detected in the contralateral carotid artery. Among all evaluated peptides, (99m)Tc-B2702p1 exhibited the most favorable properties. By γ-well counting, there was a significant 2.0-fold increase in the (99m)Tc-B2702p1 left-to-right carotid artery activity ratio (2.6 ± 0.6) and a 3.4-fold increase in the left carotid-to-blood activity ratio (1.4 ± 0.4) in comparison to (99m)Tc-B2702p (1.3 ± 0.2 and 0.4 ± 0.1, respectively, P < 0.05 for both comparisons). Similarly, planar image quantification indicated a higher left-to-right carotid activity ratio in (99m)Tc-B2702p1- than in (99m)Tc-B2702p-injected mice (1.2 ± 0.1 vs. 1.0 ± 0.0, respectively, P < 0.05). Finally, a significantly higher (99m)Tc-B2702p1 activity in the left than in the right carotid artery was observed by SPECT imaging (2.2 ± 0.4 vs. 1.4 ± 0.3 cpm/mm(2)/injected dose, respectively, P < 0.05).
CONCLUSION: (99m)Tc-B2702p1 is a potentially useful radiotracer for the in vivo molecular imaging of VCAM-1 expression in atherosclerotic plaques.

Entities:  

Keywords:  VCAM-1; molecular imaging; vulnerable atherosclerotic plaque

Mesh:

Substances:

Year:  2013        PMID: 23719858      PMCID: PMC3886675          DOI: 10.2967/jnumed.112.115675

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  Ala scan analogues of HOE 140. Synthesis and biological activities.

Authors:  L Quartara; R Ricci; S Meini; R Patacchini; A Giolitti; S Amadesi; C Rizzi; A Rizzi; K Varani; P A Borea; C A Maggi; D Regoli
Journal:  Eur J Med Chem       Date:  2000-11       Impact factor: 6.514

2.  Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo.

Authors:  Michael Schäfers; Burkhard Riemann; Klaus Kopka; Hans-Jörg Breyholz; Stefan Wagner; Klaus P Schäfers; Marilyn P Law; Otmar Schober; Bodo Levkau
Journal:  Circulation       Date:  2004-05-03       Impact factor: 29.690

3.  The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis.

Authors:  M J Davies; J L Gordon; A J Gearing; R Pigott; N Woolf; D Katz; A Kyriakopoulos
Journal:  J Pathol       Date:  1993-11       Impact factor: 7.996

4.  An immunosuppressive and anti-inflammatory HLA class I-derived peptide binds vascular cell adhesion molecule-1.

Authors:  X Ling; T Tamaki; Y Xiao; S Kamangar; C Clayberger; D B Lewis; A M Krensky
Journal:  Transplantation       Date:  2000-08-27       Impact factor: 4.939

5.  Assessing low levels of mechanical stress in aortic atherosclerotic lesions from apolipoprotein E-/- mice--brief report.

Authors:  Alexis Broisat; Jakub Toczek; Nicolas Mesnier; Philippe Tracqui; Catherine Ghezzi; Jacques Ohayon; Laurent M Riou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-10       Impact factor: 8.311

6.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

Authors:  K D O'Brien; M D Allen; T O McDonald; A Chait; J M Harlan; D Fishbein; J McCarty; M Ferguson; K Hudkins; C D Benjamin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content.

Authors:  K D O'Brien; T O McDonald; A Chait; M D Allen; C E Alpers
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

8.  Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor.

Authors:  Mélanie Van Craenenbroeck; Françoise Gregoire; Philippe De Neef; Patrick Robberecht; Jason Perret
Journal:  Peptides       Date:  2004-06       Impact factor: 3.750

9.  Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.

Authors:  Pernilla Sörme; Barbro Kahl-Knutsson; Margaret Huflejt; Ulf J Nilsson; Hakon Leffler
Journal:  Anal Biochem       Date:  2004-11-01       Impact factor: 3.365

Review 10.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

View more
  19 in total

1.  In Vivo Translation of the CIRPI System: Revealing Molecular Pathology of Rabbit Aortic Atherosclerotic Plaques.

Authors:  Raiyan T Zaman; Siavash Yousefi; Hidetoshi Chibana; Fumiaki Ikeno; Steven R Long; Sanjiv S Gambhir; Frederick T Chin; Michael V McConnell; Lei Xing; Alan Yeung
Journal:  J Nucl Med       Date:  2019-02-08       Impact factor: 10.057

2.  Scintillating balloon-enabled fiber-optic system for radionuclide imaging of atherosclerotic plaques.

Authors:  Raiyan T Zaman; Hisanori Kosuge; Colin Carpenter; Conroy Sun; Michael V McConnell; Lei Xing
Journal:  J Nucl Med       Date:  2015-04-09       Impact factor: 10.057

Review 3.  New radiotracers for imaging of vascular targets in angiogenesis-related diseases.

Authors:  Hao Hong; Feng Chen; Yin Zhang; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2014-07-30       Impact factor: 15.470

Review 4.  Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis.

Authors:  Soraya M Kazuma; Deborah Sultan; Yongfeng Zhao; Lisa Detering; Meng You; Hannah P Luehmann; Dulcineia S P Abdalla; Yongjian Liu
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle.

Authors:  Hannah P Luehmann; Eric D Pressly; Lisa Detering; Cynthia Wang; Richard Pierce; Pamela K Woodard; Robert J Gropler; Craig J Hawker; Yongjian Liu
Journal:  J Nucl Med       Date:  2014-03-03       Impact factor: 10.057

6.  The construction of multifunctional nanoparticles system for dual-modal imaging and arteriosclerosis targeted therapy.

Authors:  Pengda Qiu; Yunhong Xu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaques.

Authors:  Raiyan T Zaman; Hisanori Kosuge; Guillem Pratx; Colin Carpenter; Lei Xing; Michael V McConnell
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

8.  Imaging VEGF receptor expression to identify accelerated atherosclerosis.

Authors:  Yared Tekabe; Maria Kollaros; Adam Zerihoun; Geping Zhang; Marina V Backer; Joseph M Backer; Lynne L Johnson
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

9.  In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles.

Authors:  Yabin Wang; Jiangwei Chen; Bo Yang; Hongyu Qiao; Lei Gao; Tao Su; Sai Ma; Xiaotian Zhang; Xiujuan Li; Gang Liu; Jianbo Cao; Xiaoyuan Chen; Yundai Chen; Feng Cao
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

10.  Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.

Authors:  Johanna M U Silvola; Helena Virtanen; Riikka Siitonen; Sanna Hellberg; Heidi Liljenbäck; Olli Metsälä; Mia Ståhle; Tiina Saanijoki; Meeri Käkelä; Harri Hakovirta; Seppo Ylä-Herttuala; Pekka Saukko; Matti Jauhiainen; Tibor Z Veres; Sirpa Jalkanen; Juhani Knuuti; Antti Saraste; Anne Roivainen
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.